Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Molecule.one positions itself as an AI + automated chemistry platform for “Making Molecules, Discovering Chemistry.” Its core product, Maria™, is an AI-orchestrated high-throughput robotic synthesis platform aimed at pharmaceutical, biotech, and fine-chemicals companies. It is designed to address bottlenecks such as small-molecule synthesis slowing down discovery workflows, rising CRO costs, and limited diversity in on-demand compound space.
The website highlights its use of 300,000+ microscale experiments to map chemical reactivity, supporting retrosynthesis planning, reaction-condition recommendations, and M1 RetroScore scoring. Its services fall into two categories. The first is ordering novel molecules from the SpaceM1 / HTE-first molecular space, covering <1 mg or 1–10 mg scales, with shipping in as fast as 7 business days, and options for purified compounds or direct-to-biology screening-ready compounds. The second is end-to-end hit discovery: given an existing target and assay, the company claims it can deliver novel hits with confirmed biological activity within 4 weeks. Enterprises can also license Maria™ AI for integration into internal synthesis workflows, and train models on custom HTE data to solve specific reaction challenges.
Public pricing is not available. The site mainly directs users to Request a Quote, suggesting an enterprise-oriented, customized, project-based purchasing model. M1 RetroScore powered by CAS offers a Free trial, but the trial duration, usage limits, and commercial licensing price are not disclosed.
Its main strength is that it combines real high-throughput experimentation, robotic synthesis, and AI planning into a closed loop, rather than offering prediction software only. It also has a strategic partnership with CAS, along with case studies, publications, and industry customer validation. The limitations are also clear: success rates, reaction coverage, SLA terms, data privacy, and failure-handling mechanisms are not fully disclosed; Chinese-language support, API format, and payment methods are also not specified. For non-chemistry users, it has almost no general-purpose tooling value.
Molecule.one is better suited to pharmaceutical companies, TechBio teams, CRO management teams, and in-house synthetic chemistry groups for early-stage hit discovery, route planning, and complex condition optimization. Access from China cannot be determined from the main site, and payment methods are unknown. Domestic teams may also want to evaluate local CROs, WuXi AppTec / Pharmaron-related services, as well as alternatives such as Enamine, Schrödinger, and ASKCOS.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on molecule.one official site.
molecule.one is an Poland AI Apps provider. TG4G tracks its product information, an overall rating of 8.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach molecule.one directly.